- Featured Product
- KD/KO Validated
CLK2 Polyclonal antibody
CLK2 Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, ELISA
Conjugate
Unconjugated
Cat no : 11092-1-AP
Synonyms
Validation Data Gallery
Filter:
Tested Applications
| Positive WB detected in | A549 cells, Raji cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below |
| WB | See 4 publications below |
Product Information
11092-1-AP targets CLK2 in WB, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | CLK2 fusion protein Ag1549 相同性解析による交差性が予測される生物種 |
| Full Name | CDC-like kinase 2 |
| Calculated molecular weight | 60 kDa |
| GenBank accession number | BC014067 |
| Gene symbol | CLK2 |
| Gene ID (NCBI) | 1196 |
| RRID | AB_2082254 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for CLK2 antibody 11092-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
iScience Targeting ALDOA to modulate tumorigenesis and energy metabolism in retinoblastoma | ||
Antiviral Res Chromatin binding protein HMGN1 promotes HBV cccDNA transcription and replication by regulating the phosphorylation of histone 3
| ||
Bioorg Chem A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer |
